tirzepatide sleep issues Mounjaro/#zepbound (tirzepatide) for obesity complicated by apnea trials presented at #ADA2024 and published in @nejm1️⃣ Participants who were not receiving treatment with positive airway pressure (PAP) at baseline were enrolled in tirzepatide and sleep issues A

Stick one on, go about your day, and let your wellness routine work seamlessly in the background

Most side effects improve within the first few weeks

Bright, healthy skin is closer to you

In the SURMOUNT-1 trial, 91% of people on the highest dose lost at least 5% of their body weight by 72 weeks, and 57% lost 20% or more

Future Research Directions and Emerging Applications Systemic Administration and Biodistribution Studies While most clinical applications of GHK-Cu involve topical administration, emerging research explores systemic delivery routes including subcutaneous injection, intravenous infusion, and oral administration for potential applications in systemic inflammation, tissue remodeling, and age-related decline